Drug Shortage Report for RIVA-VENLAFAXINE XR
| Report ID | 62771 |
| Drug Identification Number | 02307774 |
| Brand name | RIVA-VENLAFAXINE XR |
| Common or Proper name | Riva- Venlafaxine |
| Company Name | LABORATOIRE RIVA INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | VENLAFAXINE |
| Strength(s) | 37.5MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100 & 500 tabs |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-10-01 |
| Actual start date | 2018-09-24 |
| Estimated end date | 2018-10-26 |
| Actual end date | 2018-10-10 |
| Shortage status | Resolved |
| Updated date | 2018-10-11 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2018-10-11 | French | Compare |
| v3 | 2018-10-11 | English | Compare |
| v2 | 2018-10-01 | French | Compare |
| v1 | 2018-10-01 | English | Compare |
Showing 1 to 4 of 4